亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會(huì)員登錄|免費(fèi)注冊(cè)|忘記密碼|管理入口 返回主站||保存桌面|手機(jī)瀏覽|聯(lián)系方式|購(gòu)物車(chē)
企業(yè)會(huì)員第1年

上海武昊經(jīng)貿(mào)有限公司  

耗材 試劑盒 鱟試劑 工作標(biāo)準(zhǔn)品
搜索
新聞中心
產(chǎn)品分類(lèi)
  • 暫無(wú)分類(lèi)
聯(lián)系方式
  • 聯(lián)系人：elisa
  • 電話(huà)：021-60875268
  • 郵件：wuhaojingmao@163.com
  • 傳真：021-60875269
  • QQ：121746930
站內(nèi)搜索
 
榮譽(yù)資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無(wú)鏈接
  供應(yīng)產(chǎn)品
人 βLPH ELISA 試劑盒 面議0詢(xún)價(jià)
人的Aurora激酶B(AURKB)ELISA 試劑盒 面議0詢(xún)價(jià)
96T,Mouse BAT3 ELISA Kit 面議0詢(xún)價(jià)
現(xiàn)貨 Mouse FABP4 ELISA Kit 面議0詢(xún)價(jià)
現(xiàn)貨 Human Anti-MPO ELISA Kit 面議0詢(xún)價(jià)
Mouse monoclonal [E11] to CD35 面議0詢(xún)價(jià)
ConA Lectin (FITC) 抗體 面議0詢(xún)價(jià)
HistostarTM rat (Ms+Rb)抗體 面議0詢(xún)價(jià)
FTL抗體/antibody、FBN2抗體 面議0詢(xún)價(jià)
human GPRC5A ELISA Kit 面議0詢(xún)價(jià)
©2025 上海武昊經(jīng)貿(mào)有限公司 版權(quán)所有   技術(shù)支持：化工網(wǎng)   訪問(wèn)量:42727  
 
主站蜘蛛池模板： | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |